Videos & Webinar

Circulating Tumor Cells in Breast Cancer: Understanding a Validated Diagnostic Tool
for Precision Medicine 

In this webinar Dr. Massimo Cristofanilli, Associate Director of Translational Research and Precision Medicine at Robert Lurie Cancer Center, Northwestern University, will review the evidence, as well as clinical case studies demonstrating how CTCs can be utilized in clinical practice and clinical research studies in metastatic breast cancer. 


Menarini Group: committed to fighting today's
COVID-19 pandemic with an eye to averting
similar health crises in the future

In a recent interview with ANSA, the CEO of the Menarini Group, Elcin Barker Ergun commented: “As we go through one of the biggest health challenges in this century, Menarini Group continues to be a key actor in the fight against the pandemic by bringing crucial Covid-19 tests to market and recently extending into therapeutic solutions, joining forces with Tuscany Life Sciences to bring an antibody against Covid-19.

We must also do everything possible to anticipate and prevent other crises such as the key threat from AMR where if not acted in a decisive way today, can turn into an even larger crisis than Covid-19 in coming years.”


Liquid Biopsy in MBC: Recognizing The Bad, The Good, and The Ugly

Dr. Massimo Cristofanilli, MD of the Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, IL discusses the use of liquid biopsy diagnostics as objective and measurable tools to evaluate the dynamic changes of Metastatic Breast Cancer (MBC) .


Utilization of DEPArray in molecular pathology for clinical diagnostics and translational research

Dr. Matija SNUDERL, from NYU Langone Health, presents his research using the DEPArray cell sorting system to isolate pure cells from archived FFPE samples


Single Cell Forensics

Dr. Katja ANSLINGER, from Ludwig-Maximilians-University of Munich, discusses her latest findings in the field of single-cell forensics



"Dissecting Genetic Heterogeneity in Brain Tumors using Digital Sorting of Single Cells"
Speakers: Matija Snuderl, MD, Department of Pathology, NYU Langone Medical Center and Medical School; Raimo Tanzi, Menarini Silicon Biosystems


"Liquid biopsy: CTC-based classifier predicts chemo resistance in lung cancer"
Speakers: C. Dive, CRUK; N. Manaresi, Menarini Silicon Biosystems
To view the webinar register in Nature Webcast page HERE.

"CLIA Validation of DEPArray to Overcome Limitations Associated with Current Oncological Techniques"


VRNxT video tutorial


Discover the new VRNxT™, a volume reduction instrument optimized to remove manual sample volume reduction steps in cellular biology workflows




DEPArray technology overview



Discover DEPArray NxT




Resolving FFPE Tumor Sample Heterogeneity with DEPArray™ Technology